skip to main content
Idioma:
Refinado por: Nome da Publicação: European Heart Journal remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The early termination of clinical trials: causes, consequences, and control
The early termination of clinical trials: causes, consequences, and control
Material Type:
Artigo 		Adicionar ao Meu Espaço

The early termination of clinical trials: causes, consequences, and control

TASK FORCE OF THE WORKING GROUP ON ARRHYTHMIAS OF THE EUROPEAN SOCIETY OF CARDIOLOGY

European heart journal, , Vol.15 (6), p.721-738 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
2
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials

Metra, Marco ; Eichhorn, Eric ; Abraham, William T. ; Linseman, Jennifer ; Böhm, Michael ; Corbalan, Ramon ; DeMets, David ; De Marco, Teresa ; Elkayam, Uri ; Gerber, Michael ; Komajda, Michel ; Liu, Peter ; Mareev, Vyacheslev ; Perrone, Sergio V. ; Poole-Wilson, Philip ; Roecker, Ellen ; Stewart, Jennifer ; Swedberg, Karl ; Tendera, Michal ; Wiens, Brian ; Bristow, Michael R.

European heart journal, 2009-12, Vol.30 (24), p.3015-3026 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
3
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Gullestad, Lars ; Ueland, Thor ; Kjekshus, John ; Nymo, Ståle H ; Hulthe, Johannes ; Muntendam, Pieter ; Adourian, Aram ; Böhm, Michael ; van Veldhuisen, Dirk J ; Komajda, Michel ; Cleland, John G F ; Wikstrand, John ; McMurray, John J V ; Aukrust, Pål

European heart journal, 2012-09, Vol.33 (18), p.2290-2296 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
4
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

Docherty, Kieran F ; Jhund, Pardeep S ; Inzucchi, Silvio E ; Køber, Lars ; Kosiborod, Mikhail N ; Martinez, Felipe A ; Ponikowski, Piotr ; DeMets, David L ; Sabatine, Marc S ; Bengtsson, Olof ; Sjöstrand, Mikaela ; Langkilde, Anna Maria ; Desai, Akshay S ; Diez, Mirta ; Howlett, Jonathan G ; Katova, Tzvetana ; Ljungman, Charlotta E A ; O’Meara, Eileen ; Petrie, Mark C ; Schou, Morten ; Verma, Subodh ; Vinh, Pham Nguyen ; Solomon, Scott D ; McMurray, John J V

European heart journal, 2020-07, Vol.41 (25), p.2379-2392 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
5
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)

Serenelli, Matteo ; Böhm, Michael ; Inzucchi, Silvio E ; Køber, Lars ; Kosiborod, Mikhail N ; Martinez, Felipe A ; Ponikowski, Piotr ; Sabatine, Marc S ; Solomon, Scott D ; DeMets, David L ; Bengtsson, Olof ; Sjöstrand, Mikaela ; Langkilde, Anna Maria ; Anand, Inder S ; Chiang, Chern-En ; Chopra, Vijay K ; de Boer, Rudolf A ; Diez, Mirta ; Dukát, Andrej ; Ge, Junbo ; Howlett, Jonathan G ; Katova, Tzvetana ; Kitakaze, Masafumi ; Ljungman, Charlotta E A ; Verma, Subodh ; Docherty, Kieran F ; Jhund, Pardeep S ; McMurray, John J V

European heart journal, 2020-09, Vol.41 (36), p.3402-3418 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.